These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 141075)

  • 1. [Nephrotic syndrome presumable caused by an complex glomerulonephritis (author's transl)].
    Seelig HP; Seelig R; Fischer K; Maurer R; Safer A; Schnitzlein W
    Res Exp Med (Berl); 1977 Apr; 169(1):35-55. PubMed ID: 141075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serious side effects with D-penicillamine therapy for Wilson's disease].
    Storch W; Lössner J; Ruchholtz U
    Psychiatr Neurol Med Psychol (Leipz); 1979 Sep; 31(9):531-8. PubMed ID: 161403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Perimembranous glomerulonephritis after treatment with D-penicillamine. Report on 31 cases (author's transl)].
    Gärtner HV; Neild GH; Bohle A; Hallauer W; Hoppe-Seyler G; Lüttgen FM; Schollmeyer P
    Klin Wochenschr; 1975 Sep; 53(17):835-7. PubMed ID: 1195663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma exchange in the successful treatment of drug-induced renal disease.
    Swainson CP; Thomson D; Short AI; Winney RJ
    Nephron; 1982; 30(3):244-9. PubMed ID: 7099337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immune complex nephritis with nephrotic syndrome following D-penicillamine therapy].
    Hallauer W; Gärtner HV; Kronenberg KH; Manz G
    Schweiz Med Wochenschr; 1974 Mar; 104(12):434-8. PubMed ID: 4820540
    [No Abstract]   [Full Text] [Related]  

  • 6. [Proteinuria and nephrotic syndrome in penicillamine therapy. Reversibility of immunopathologic findings in animal experiments].
    Seelig HP; Seelig R
    Dtsch Med Wochenschr; 1977 Jul; 102(28):1035-6. PubMed ID: 891372
    [No Abstract]   [Full Text] [Related]  

  • 7. Penicillamine induced membranous glomerulonephritis.
    Neild GH; Gärtner HV; Bohle A
    Scand J Rheumatol Suppl; 1979; (28):79-90. PubMed ID: 287195
    [No Abstract]   [Full Text] [Related]  

  • 8. [Penicillamine-induced glomerulonephritis].
    Koall W; Mampel E
    Z Urol Nephrol; 1977 Jan; 70(1):13-7. PubMed ID: 848141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of the membrane attack complex (MAC) in experimental immune complex glomerulonephritis.
    Koffler D; Biesecker G; Noble B; Andres GA; Martinez-Hernandez A
    J Exp Med; 1983 Jun; 157(6):1885-905. PubMed ID: 6343549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of D-penicillamine administration to rats, induction of renal changes: preliminary communication.
    Batsford SR; Rohrbach R; Riede UN; Sandritter W; Kluthe R
    Clin Nephrol; 1976 Sep; 6(3):394-7. PubMed ID: 991466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study.
    Bacon PA; Tribe CR; Mackenzie JC; Verrier-Jones J; Cumming RH; Amer B
    Q J Med; 1976 Oct; 45(180):661-84. PubMed ID: 1005658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of C3d deposits in membranous nephropathy.
    Doi T; Kanatsu K; Nagai H; Suehiro F; Kuwahara T; Hamashima Y
    Nephron; 1984; 37(4):232-5. PubMed ID: 6379483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hodgkin's disease complicated with autoimmune thrombocytopenic purpura and a nephrotic syndrome due to deposition of circulating immunocomplexes (author's transl)].
    Zuazu Nagore J; Juliá Font A; Torrabadella Reynoso M; Darnell Tey A; Torras Rabasa A; Sans Boix A
    Med Clin (Barc); 1981 Jan; 76(2):65-9. PubMed ID: 6452558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delay in growth and the development of nephritis in rats treated with interferon preparations in the neonatal period.
    Gresser I; Morel-Maroger L; Châtelet F; Maury C; Tovey M; Bandu MT; Buywid J; Delauche M
    Am J Pathol; 1979 May; 95(2):329-46. PubMed ID: 156503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesangial disposal of glomerular immune deposits in acute malarial glomerulonephritis of rats.
    Sterzel RB; Ehrich JH; Lucia H; Thomson D; Kashgarian M
    Lab Invest; 1982 Feb; 46(2):209-14. PubMed ID: 7038293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunohistological study of feline glomerulonephritis using the peroxidase-antiperoxidase method.
    Arthur JE; Lucke VM; Newby TJ; Bourne FJ
    Res Vet Sci; 1984 Jul; 37(1):12-7. PubMed ID: 6382492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgM nephropathy after D-penicillamine therapy: report of a case.
    Liao K; Huang CC; Ho HH; Wu CH; Hsueh S
    Taiwan Yi Xue Hui Za Zhi; 1987 Aug; 86(8):906-9. PubMed ID: 3681258
    [No Abstract]   [Full Text] [Related]  

  • 18. Membranoproliferative glomerulonephritis. Localization of early components of complement in glomerular deposits.
    Davis BK; Cavallo T
    Am J Pathol; 1976 Aug; 84(2):283-98. PubMed ID: 133617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Membranous glomerulonephritis caused by D-penicillamine].
    Bécares Lozano MM; Pascual Izuel JM; Mateos Sánchez A; Delgado Martínez J; Querol Prieto R; Flores Corral T
    Rev Clin Esp; 1982 Mar; 164(6):411-2. PubMed ID: 7111809
    [No Abstract]   [Full Text] [Related]  

  • 20. Penicillamine-induced rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis.
    Almirall J; Alcorta I; Botey A; Revert L
    Am J Nephrol; 1993; 13(4):286-8. PubMed ID: 8267029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.